Image

The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction

The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction

Recruiting
18-55 years
All
Phase N/A

Powered by AI

Overview

The aim of the study is the evaluation of both clinical and radiological results in patients undergone to cruciate ligament reconstruction with concomitant cartilaginous lesion treated with or without nanofractures.

Description

The anterior cruciate ligament lesion is one of the most common disease conditions in the orthopedic clinical practice. The mechanism of injury is due to a direct or indirect knee trauma causing both ligamentous breaking and surface articular stress, with cartilaginous lesion often associated to the lesion of the anterior cruciate ligament.

The treatment of these lesions in combination with the treatment of the anterior cruciate ligament is controversial, more controversial is to understand the indication to treatment for these lesions.

In order to clarify this aspect and provide a more reliable therapeutic indication for the treatment of the cartilaginous lesion with concomitant anterior cruciate ligament lesion we want to compare the clinical outcomes of the non-treated cartilaginous lesions against the treated cartilaginous lesions wiht nonofractures.

Eligibility

Inclusion Criteria:

  1. Male or female patients, 18 < age < 55;
  2. Patients with complete ACL injury candidates for surgical reconstruction of the same;
  3. Cartilaginous lesion of the femur-tibial compartment of grade III-IV ICRS ≤3 cm2 confirmed intra-operatively;
  4. Patients without evidence of osteoarthritis
  5. Patients' ability and consent to participate in clinical and radiological follow-up;
  6. Signature of informed consent.

Exclusion Criteria:

  1. Patients incapable of understanding and of wanting;
  2. State of immunodepression;
  3. Patients with malignant neoplasms;
  4. Patients suffering from rheumatic diseases;
  5. Patients suffering from non-compensated diabetes;
  6. Patients suffering from uncompensated thyroid metabolic disorders;
  7. Patients abusing alcoholic beverages, drugs or drugs;
  8. Patients with axial deviations> 5 °;
  9. Body Mass Index> 35;
  10. Patients treated with surgery at the same knee in the previous 12 months.
  11. Cartilaginous lesions grade I-II according to the ICRS score.
  12. Cartilage lesions with a diameter greater than 3 cm².
  13. Non-suturable meniscal lesions requiring meniscectomy> 50% and patients with previous meniscectomies> 50% in the same compartment.
  14. Need for further associated surgical procedures in addition to the reconstruction of ACL and possibly the nanofractures.

Study details
    Cruciate Ligament Rupture
    Cartilage Injury

NCT04184687

Istituto Ortopedico Rizzoli

19 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.